Get notified regarding key financial metrics and revenue changes at Amal TherapeuticsLearn more
Banner background

Summary - Funding Rounds

Total Funding

$45.5 m

Investors

In total, Amal Therapeutics had raised $45.5 m. Amal Therapeutics is a subsidiary of Boehringer Ingelheim